Dr. Noaline Sinha

Dr Noaline Sinha is the Chairperson of Nuclear Medicine and Radio-Theranostics at Artemis Hospital, Gurugram, and one of North India's most experienced nuclear medicine physicians in Gurugram, with 30 years of clinical experience since completing her MBBS in 1996.

She is the Past President of the Society of Nuclear Medicine India, Northern Chapter, and is recognised as a clinical governance, theranostics, and PET-CT expert.

Trained at Lady Hardinge Medical College, University of Delhi (MBBS 1996), the Institute of Nuclear Medicine and Allied Sciences (INMAS), University of Delhi (Diploma in Radiation Medicine 2002), and Symbiosis International University (PGDHHM 2020).

Dr Sinha specialises in PET-CT imaging (whole body, cardiac, and brain), myocardial perfusion imaging (MPI), radio-theranostics, High-Dose I-131 therapy for thyroid cancer, Lu-177 PRRT for neuroendocrine tumours and prostate cancer, and TARE (Y-90 radioembolisation) for liver cancer.

She is AERB-registered and certified for radio-isotope administration, and an active member of the SNMI, ANMPI, and WARMTH. She holds an RSO (Radiation Safety Officer) Certification. She consults in English and Hindi.

Specialty Areas and Treatments

PET-CT and Hybrid Molecular Imaging in Gurugram

A flagship area of practice, with deep experience in oncology, cardiology, and neurology imaging:

• Whole-Body PET-CT (FDG) for cancer staging, restaging, and treatment response
• Cardiac PET-CT for myocardial viability and perfusion
• F-DOPA Brain PET-CT for Parkinson's disease and movement disorders
• Ga-68 DOTANOC / DOTATATE PET-CT for neuroendocrine tumours
• Ga-68 PSMA PET-CT for prostate cancer staging and recurrence
• PET-CT for radiotherapy planning
• Hybrid SPECT-CT for subtle musculoskeletal, renal, and oncologic findings

Radio-Theranostics and Targeted Radionuclide Therapy

A signature area of expertise where Dr N Sinha pioneers personalised, biology-driven cancer therapy:

• High-Dose I-131 Therapy for thyroid cancer
• I-131 MIBG Therapy for neuroblastoma and neuroendocrine tumours
• Lu-177 DOTATATE PRRT for neuroendocrine tumours (NET)
• Lu-177 PSMA Therapy for advanced prostate cancer
• Y-90 TARE (Transarterial Radioembolisation) for liver cancer (HCC and metastases)
• Salvage and re-induction PRRT in refractory cases
• Personalised theranostic strategy based on receptor imaging

Cardiac Nuclear Medicine

A long-standing area of practice from her Max Heart and Vascular Institute years:

• Myocardial Perfusion Imaging (MPI) with stress and rest protocols
• Cardiac PET-CT for viability assessment
• Pre-CABG and pre-revascularisation cardiac evaluation
• Sarcoidosis cardiac PET imaging
• Functional assessment of ischaemic heart disease

Thyroid Nuclear Medicine and Theranostics

• Thyroid scintigraphy for nodules and thyroiditis evaluation
• Differentiated Thyroid Cancer (DTC) workup and staging
• High-Dose I-131 ablation post-thyroidectomy
• rhTSH-stimulated I-131 therapy (per ATA and EANM guidelines)
• Thyroid hormone withdrawal protocols
• Recurrent and metastatic thyroid cancer management
• Long-term thyroid cancer surveillance

Oncology Nuclear Medicine

A core sub-specialty, integrated with the Artemis Cancer Centre:

• Cancer staging and restaging with PET-CT
• Treatment response assessment
• Recurrence detection in suspected cancer
• Neuroendocrine tumour (NET) workup with DOTANOC PET
• Prostate cancer workup with PSMA PET
• Multidisciplinary tumour board participation

Bone, Renal, and Functional Imaging

• 99mTc-MDP Bone Scan for cancer metastases and bone pain
• SPECT-CT bone imaging for occult fractures and pain generators
• 99mTc-DMSA Renal Scan for cortical evaluation
• DTPA / EC Renal Scan for differential function and obstruction
• Hepatobiliary (HIDA) Scan for gallbladder and bile duct disorders
• Lung Perfusion Scan (V/Q) for pulmonary embolism

Intra-Operative Nuclear Medicine

A unique skill area, especially for sentinel node and tumour localisation:

• Hand-Held Gamma Probe intra-operative use
• Sentinel Lymph Node Biopsy (SLNB) in breast and melanoma
• Parathyroid gamma probe localisation
• Radioguided occult lesion localisation (ROLL)

Nuclear Medicine for Movement and Neurodegenerative Disorders

A growing area aligned with India's rising Parkinson's disease burden:

• F-DOPA PET-CT for early Parkinson's diagnosis
• Dopaminergic neuron evaluation
• Differential diagnosis of Parkinson's vs other parkinsonian syndromes
• PET imaging in dementia workup

Diagnostic and Therapy Procedures

• Whole-body PET-CT studies (FDG, DOTA, PSMA, F-DOPA)
• Cardiac PET and MPI
• High-Dose I-131 therapy
• Lu-177 PRRT (DOTATATE and PSMA)
• Y-90 TARE
• Hand-held gamma probe procedures
• Bone, renal, hepatobiliary, lung, thyroid scintigraphy

Credentials and Trust Signals

Dr Noaline Sinha holds qualifications from premier Delhi University-affiliated institutions, with strong regulatory and management credentials:

• MBBS from Lady Hardinge Medical College (LHMC), University of Delhi (1996)
• Diploma in Radiation Medicine from the Institute of Nuclear Medicine and Allied Sciences (INMAS), University of Delhi (2002)
• Post Graduate Diploma in Hospital and Healthcare Management (PGDHHM) from Symbiosis International University (2020)
• Radiation Safety Officer (RSO) Certification
• AERB-registered and certified for the administration of radio-isotopes
• MCI Registration No. 15832
• DMC Registration No. 8097

Awards, Leadership, and Academic Contributions

Dr Sinha has held senior leadership roles in nuclear medicine and contributed actively to clinical governance and education:

• Past President, Society of Nuclear Medicine India, Northern Chapter
• Active Member, Society of Nuclear Medicine India (SNMI)
• Member, Association of Nuclear Medicine Physicians of India (ANMPI)
• Member, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
• Mentor and clinical governance expert in nuclear medicine
• Theranostics expert, with published case discussions on rare and refractory cancers
• Played a major role in guiding the Department of Nuclear Medicine and PET-CT through successive NABH accreditation cycles in her previous hospital, designing complete workflow processes and documentation
• Contributions to medical literature with publications in reputed national and international journals
• Active participant and speaker at national and international nuclear medicine forums

Current Hospital Affiliations and Past Experience

Dr Noaline Sinha currently serves as Chairperson of Nuclear Medicine and Radio-Theranostics at Artemis Hospital, Sector 51, Gurugram, where she leads diagnostic PET-CT, SPECT-CT, and full theranostic therapy services. Consultation timings: Monday to Friday, 11:00 AM to 2:00 PM. Consultation fee: ₹1,400.

Before her current role, Dr Sinha built her career across some of Delhi NCR's top nuclear medicine departments:

• Consultant, Department of Nuclear Medicine at Max Heart and Vascular Institute, Saket, New Delhi
• Senior Registrar, Department of Nuclear Medicine at Apollo Hospitals, New Delhi
• Senior Registrar, Department of Nuclear Medicine at Batra Hospital, New Delhi

About Artemis Hospital, Gurugram

Artemis Hospital, Sector 51, Gurugram, is a 525,000 sq. ft. multispecialty tertiary care hospital and the first JCI and NABH accredited super speciality hospital in Gurgaon.

Established in 2007 by the promoters of the Apollo Tyres Group, the hospital houses one of North India's most advanced Nuclear Medicine and Radio-Theranostics departments, with PET-CT, SPECT-CT, and dedicated theranostics therapy facilities.

The department works in close coordination with the Artemis Cancer Centre, Heart Centre, and Neurosciences Centre to support precision diagnosis and personalised radionuclide therapy for patients across India and more than 100 countries.

Book an Appointment with Dr Noaline Sinha

Book a priority appointment with Dr Noaline Sinha, Chairperson of Nuclear Medicine and Radio-Theranostics in Gurugram, on HexaHealth to confirm your slot in minutes.